Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1985-10-08
1988-05-17
Rollins, John
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
4241951, 514885, 514937, 514938, A61K 3902, A61K 3578
Patent
active
047449845
ABSTRACT:
The present invention relates to an immunotherapeutic agent that is effective in treating a wide variety of ongoing viral infections in animals and man. The present invention is a preparation of modified mycobacterial cell walls that is capable of stimulating the immune system of an animal or man in such a way as to cause the body to neutralize, abort or eliminate an virus infection.
REFERENCES:
patent: 3331741 (1967-07-01), Anschel et al.
patent: 4069314 (1978-01-01), Adlam et al.
patent: 4340586 (1982-07-01), Bekierkunst et al.
patent: 4503048 (1985-03-01), Cartrell
patent: 4504473 (1985-03-01), Cartrell
patent: 4505903 (1985-03-01), Cartrell
patent: 4520019 (1985-05-01), Ribi et al.
Regression of Tumors in Guinea Pigs After Treatment with Synthetic Muramyl Dipeptides and Trehalose Dimycolate, Science, vol. 208, pp. 415-416, 1980, Charles A. McLaughlin, Steven M. Schwartzman, etc.
In Vitro Effects of Lipopolysaccharides and Mycobacterial Cell Wall Components on Swine Alveolar Macrophages, Research in Veterinary Science, pp. 212-217, vol. 34, 1983, B. Charley, C. Leclerc, E. Petit, L. Chedid.
Synthetic Immunostimulants Derived from the Bacterial Cell Wall, Journal of Medicinal Chemistry, vol. 23, No. 8, pp. 819-821, 1980, Edgar Lederer.
Immunologic Effects of BCG in Patients with Malignant Melanoma: Specific Evidence for Stimulation of the "Secondary" Immune Response, Journal of the National Cancer Institute, vol. 51, No. 1, pp. 57-65, 1973, Leonard Chess, M.D., Gerald N. Bock, M.D., etc.
BCG and Cancer, New England Journal of Medicine, vol. 290, Nos. 25 and 26, pp. 1413-1420 and 1458-1469, 1974, Robert C. Bast, Jr., M.D., Berton Zbar, M.D., etc.
Enhancement of Nonspecific Immunity to Klebsiella Pneumoniae Infection by a Synthetic Immunoadjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine) and Several Analogs, Proceedings of the National Academy of Science U.S.A., Vol. 74, pp. 2089-2093, 1977, L. Chedid, M. Parant, etc.
The Activation of Human Monocytes by Liposome-Encapsulated Muramyl Dipeptide Analogues, The Journal of Immunology, vol. 133, No. 4, pp. 1500-1502, 1983, Gabriel Lopez-Berestein, Kapil Mehta, etc.
Human Monocytes Activated by Immunomodulators in Liposomes Lyse Herpesvirus-Infected but Not Normal Cells, Science, vol. 224, pp. 1007-1009, Wayne C. Koff, Isaiah J. Fidler, etc.
Rollins John
Vetrepharm Research, Inc.
LandOfFree
Antiviral immunotherapeutic agent and preparation thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antiviral immunotherapeutic agent and preparation thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiviral immunotherapeutic agent and preparation thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1880606